Squarepoint
QTTB icon

Squarepoint’s Q32 Bio QTTB Stock Holding History

Squarepoint’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,528
Closed -$24K – 5172
2025
Q1 		$24K Sell
14,528
-4,481
-24% -$12.1K ﹤0.01% 4424
2024
Q4 		$65.4K Buy
+19,009
New +$600K ﹤0.01% 4796
2023
Q3 		– Sell
-567
Closed -$9.03K – 4334
2023
Q2 		$9.03K Buy
+567
New +$10.2K ﹤0.01% 3498
2021
Q2 		– Sell
-1,056
Closed -$179K – 3771
2021
Q1 		$179K Buy
+1,056
New +$222K ﹤0.01% 2742
2020
Q1 		– Sell
-1,631
Closed -$608K – 2629
2019
Q4 		$608K Buy
+1,631
New +$467K ﹤0.01% 1651
2019
Q3 		– Sell
-611
Closed -$215K – 2725
2019
Q2 		$215K Buy
+611
New +$240K ﹤0.01% 2083

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint's QTTB Position: Q2 2025 in Review

Squarepoint sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 14,528 shares — an estimated $24K sold.

Squarepoint first reported a position in QTTB in Q2 2019 and held it in 6 quarters. The position peaked at $608K in Q4 2019. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Squarepoint reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 14,528 Q32 Bio shares in Q2 2025, an estimated $24K.
  • Squarepoint first reported a position in Q32 Bio in Q2 2019 and held it in 6 quarters.
  • Squarepoint's Q32 Bio position peaked at $608K in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.